Announced Tue, 8 Sept, 2026 · 23:08 IST

Board appoints new Managing Director and Independent Director

Ceo Appointed ExternalManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.5%Reaction day

₹1.10

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-4.4% vs market

Non Banking Financial Company (NBFC) peers, median of 218sector+0.0%-4.5% vs sector

On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 4.5 pts less than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.5-0.2-4.4+0.0-4.5

Next day

-7.3-0.3-6.9-0.2-7.0

-6.4-0.2-6.1-0.3-6.1

-4.5-3.5-1.0-1.4-3.2

-4.5-3.6-0.9-1.7-2.8

-5.5-2.8-2.6-1.3-4.1

-4.5-1.4-3.2-0.7-3.8

15d

-7.3-3.0-4.3-2.6-4.7

+6.4-4.4+10.8-3.6+10.0

—————

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 218Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Goyal Associates board approved Mr. Ajay Solanki as Additional Director and Managing Director effective September 8, 2026, subject to shareholder approval. He brings banking sector and DSA experience. The board also appointed Mr. Ankush Pandey as Additional Independent Director, with expertise in corporate law and SEBI compliance. Neither holds shares in the company, has other listed directorships, nor has been debarred by SEBI.

Likely market impact

New MD and Independent Director strengthen leadership. MD appointment awaits shareholder approval.